CASTRATION SENSITIVE PROSTATE CANCER
Clinical trials for CASTRATION SENSITIVE PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION SENSITIVE PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATION SENSITIVE PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart scans may slash radiation doses for metastatic prostate cancer
Disease control Not yet recruitingThis early-phase trial explores whether PSMA PET scans can help doctors adjust radiation therapy for men with prostate cancer that has spread to 4 to 20 spots in the body. Participants receive standard hormone therapy plus a special PET scan, then targeted radiation to all visibl…
Matched conditions: CASTRATION SENSITIVE PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Targeted radiation plus hormone therapy may slow Low-Volume prostate cancer spread
Disease control Not yet recruitingThis phase II trial tests whether adding a targeted radiation drug (177Lu-PSMA-617) to standard hormone therapy, with or without additional hormone-blocking pills, can better control low-volume metastatic hormone-sensitive prostate cancer. The study enrolls men whose cancer has s…
Matched conditions: CASTRATION SENSITIVE PROSTATE CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC